TXA is an inexpensive (approximately $3 per gram) and widely available antifibrinolytic medication with an established safety ...

Subfascial administration of tranexamic acid significantly reduced the need for blood transfusions in older patients undergoing intramedullary nailing for intertrochanteric fractures, according to ...

When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent total knee arthroplasty had a clinically significant reduction in blood loss by 37% at 24 ...

When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) ...

Tranexamic acid (TXA) is currently being administered to injured patients by many prehospital air and ground systems, despite a lack of evidence supporting or refuting its efficacy in preventing ...

Safety of tranexamic acid (TXA), even at higher doses, was upheld in a meta-analysis. Across 216 randomized trials in various medical disciplines, the incidence of thromboembolic events -- including ...

Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in ...

Included studies. We included 49 studies with a total of 10,591 participants in this meta-analysis. The detailed characteristics of all included studies were listed in Additional file 3 One thing ...

A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...